Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Czernik

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical, Cosmetic and Investigational Dermatology|October 13, 2016
Paraneoplastic pemphigus: a short reviewMarta Wieczorek, Annette Czernik
Archives of Dermatology|May 21, 2008
Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodiesAnnette Czernik, Jean-Claude Bystryn
Journal of the American Academy of Dermatology|April 22, 2008
Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigusAnnette Czernik, Ernst H Beutner, Jean-Claude Bystryn
Journal of the American Academy of Dermatology|August 10, 2010
Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodiesMargarita Lolis, Siavash Toosi, Annette Czernik, et al.
International Journal of Dermatology|July 26, 2011
Paraneoplastic autoimmune multiorgan syndrome: 20 years afterAnnette Czernik, Michael Camilleri, Mark R Pittelkow, et al.
Autoimmunity|September 20, 2011
Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an updateAnnette Czernik, Siavash Toosi, Jean-Claude Bystryn, et al.
Pediatric Dermatology|October 26, 2016
Case of Pediatric Bullous Systemic Lupus Erythematosus Treated with Intravenous ImmunoglobulinMargit Juhász, Megan Rogge, Mary Chen, et al.
Journal of the American Academy of Dermatology|March 18, 2020
Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case seriesRana Abdat, Reid A Waldman, Valeria de Bedout, et al.
The Journal of Allergy and Clinical Immunology|August 29, 2015
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewingMayte Suárez-Fariñas, Benjamin Ungar, Shinji Noda, et al.
Journal of the American Academy of Dermatology|February 14, 2018
Diagnosis and management of pemphigus: Recommendations of an international panel of expertsDedee F Murrell, Sandra Peña, Pascal Joly, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical, Cosmetic and Investigational Dermatology|October 13, 2016
Paraneoplastic pemphigus: a short reviewMarta Wieczorek, Annette Czernik
Archives of Dermatology|May 21, 2008
Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodiesAnnette Czernik, Jean-Claude Bystryn
Journal of the American Academy of Dermatology|April 22, 2008
Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigusAnnette Czernik, Ernst H Beutner, Jean-Claude Bystryn
Journal of the American Academy of Dermatology|August 10, 2010
Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodiesMargarita Lolis, Siavash Toosi, Annette Czernik, et al.
International Journal of Dermatology|July 26, 2011
Paraneoplastic autoimmune multiorgan syndrome: 20 years afterAnnette Czernik, Michael Camilleri, Mark R Pittelkow, et al.
Autoimmunity|September 20, 2011
Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an updateAnnette Czernik, Siavash Toosi, Jean-Claude Bystryn, et al.
Pediatric Dermatology|October 26, 2016
Case of Pediatric Bullous Systemic Lupus Erythematosus Treated with Intravenous ImmunoglobulinMargit Juhász, Megan Rogge, Mary Chen, et al.
Journal of the American Academy of Dermatology|March 18, 2020
Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case seriesRana Abdat, Reid A Waldman, Valeria de Bedout, et al.
The Journal of Allergy and Clinical Immunology|August 29, 2015
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewingMayte Suárez-Fariñas, Benjamin Ungar, Shinji Noda, et al.
Journal of the American Academy of Dermatology|February 14, 2018
Diagnosis and management of pemphigus: Recommendations of an international panel of expertsDedee F Murrell, Sandra Peña, Pascal Joly, et al.
Pageof 1